CenterWatch: Clinical Trials in Category (390) Metastatic Cancer

The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Clinical Trials

Bookmark | Print | E-Mail

Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Oncology

Metastatic Cancer

State

California
Florida
Illinois
Kentucky
Massachusetts
Michigan
New York
Ohio
Texas

Country

Australia
Austria
Belgium
Finland
France
Germany
Italy
Korea
Lithuania
Norway
Peru
Poland
Portugal
Russian Federation
Spain
Sweden
Taiwan
United Kingdom

California

Duarte : City of Hope

A Phase II Open Label Study of Brivanib (BMS-582664), Administered Orally at a Dose of 800mg Daily in Subjects with Unsectable, Locally Advanced or Metastatic Hepatocellular Carcinoma Who Have Received Either No Prior Systemic Therapy or One Prior Regimen of Angiogenesis Inhibitor Therapy

Duarte : City of Hope

PHII-80 PHL-051 NCI #7502: A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas

Santa Monica : Premiere Oncology

A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors

Santa Monica : Premiere Oncology

A Phase I Study of Single Agent LY2584702 in Patients with Advanced or Metastatic Cancer

Florida

Aventura : South Florida Medical Research

Phase II, Clinical Trial For Patients with Prostate Cancer or Breast Cancer with Metastatic Disease

Gainesville : Gainesville Hematology/ Oncology Associates

A Randomized Phase III Trial of Cetuximab, Bevacizumab and Biweekly Infusional 5-FU/Leucovorin (FOLF-CB) versus Oxaliplatin, Bevacizumab, and Biweekly Infusional 5-FU/Leucovorin (Bev-FOLFOX) in First-line Treatment of Metastatic Colorectal Cancer

Gainesville : Gainesville Hematology/ Oncology Associates

A Randomized, Phase 2B Study of Sunitinib Plus Oxaliplatin, 5-FU, and Leucovorin (FOLFOX)versus Bevacizumab Plus FOLFOX as First-line Treatment in Patients with Metastatic Colorectal Cancer

Illinois

Centralia : Southern Illinois Hematology/Oncology

This is a Phase 2 study to evaluate the efficacy and safety of NKTR-102 (a pegylated Irinotecan) in patients with breast cancer.

Kentucky

Louisville : Norton Health Care

This is a Phase 2 study to evaluate the efficacy and safety of NKTR-102 (a pegylated Irinotecan) in patients with breast cancer.

Massachusetts

Boston : Massachusetts General Hospital Cancer Center

An open-label dose escalation study of patients with solid tumors treated with STA-9090

Boston : Beth Israel Deaconess Medical Center (BIDMC) - Cancer Center

An open-label dose escalation study of patients with solid tumors treated with STA-9090

Boston : Dana Farber Cancer Institute

An open-label dose escalation study of patients with solid tumors treated with STA-9090

Michigan

Detroit : Karmanos Cancer Institute Wayne State University

An open-label dose escalation study of patients with solid tumors treated with STA-9090

New York

Bronx : Einstein-Montefiore Institute for Clinical & Translational Research

A Pilot Feasibility Study of a Low Carbohydrate Diet In patients with Advanced Cancer. {Also known as the RECHARGE Trial (REduced CarboHydrates Against REsistant Growth Tumors).}

Manhasset : Biomedical Research Alliance of New York

Metastatic Cancer to the Brain - Adults

Ohio

Kettering : US Oncology Dayton Oncology and Hematology, P.A.

A Phase 1 Study of STA-9090, Administered Once-Weekly in Patients with Solid Tumors

Texas

Houston : University of Texas MD Anderson Cancer Center

Do you suffer from spine pain due to broken bones in the back that may have been caused by prostate or breast cancer? You are being asked to take part in this study because you have one or more painful broken bones in your back that may have been caused by cancer. Your doctor has also recommended that you receive surgery for the broken bone(s).

Australia

BEDFORD PARK, SA : Research Site